Industry News
Latest orthopaedic industry news on orthopaedic companies, devices, implants & technology trends.
- Written by Editor-in-Chief
- Category: Industry News
Medical device and robotic surgery history is heading to the Smithsonian’s Natural Museum of American History, in the form of a 1989 prototype of Robodoc, an early orthopedic surgical robot. The Robodoc device was created for use in hip and knee replacement surgeries, the Smithsonian said, and its donation came along with a wealth of archival material.
- Written by Editor-in-Chief
- Category: Industry News
PARIS & SAN FRANCISCO–(BUSINESS WIRE)–SpineGuard (FR0011464452 – ALSGD) announced today that it has received an award from Orthopedics this Week, one of the most widely read publications in the Orthopedics industry, recognizing SpineGuard’s innovative DSG™ (Dynamic Surgical Guidance) Screw as one of the BEST new spine care technologies for 2016. The award was received during the 31st annual meeting of the North American Spine Society (NASS) in Boston. The DSG™ Screw is a pedicle screw with a unique combination of a bipolar sensor with a pedicle screw—in just one device. The technology gives surgeons real-time guidance and the ability to insert the screw directly into a vertebra without drilling a pilot hole.
- Written by Editor-in-Chief
- Category: Industry News
Download the PDF Yet another year has flown past and, as far as notable infosec happenings are concerned, this is one for the history books.Drama, intrigue and exploits have plagued 2016 and, as we take stock of some of the more noteworthy stories, we once again cast our gaze forward to glean the shapes of the 2017 threat landscape. Rather than thinly-veiled vendor pitching, we hope to ground these predictions in trends we’ve observed in the course of our research and provide thought-provoking observations for researchers and visitors to the threat intelligence space alike.
- Written by James Chisum
- Category: Industry News
The Press Ganey Pinnacle of Excellence Award recognizes top-performing health care organizations nationwide on the basis of extraordinary achievement and consistently high levels of excellence for three years in patient experience. HOI earned the Guardian of Excellence Award for maintaining a high level of excellence in the area of Patient Experience. The award criteria was maintaining the 95th percentile or higher in overall rating by inpatients.
- Written by Editor-in-Chief
- Category: Industry News
Here are six takeaways: 1. The aging population and increasing number of neurological disorder cases will spur market growth in the forecast period. 2. A dearth of skilled professionals in developing countries as well as unfavorable reimbursements will hinder the market. 3. Currently, North America dominates the market, because of the high neurosurgical case volume in this region. 4. Europe follows North America in market share, because of its technological advancements in the healthcare industry. 5. The Asia-Pacific region is anticipated to grow, due to market opportunity in India and China. 6. Key market players include:
- Written by Editor-in-Chief
- Category: Industry News
CHARLOTTESVILLE, Va. (NEWSPLEX) -- A national list says part of the University of Virginia Medical Center is one of the best in the country. UVA Orthopedics was listed as one of the Becker's Hospital Review's 100 Hospitals with Great Orthopedic Programs 2016. "I'm thrilled to see our team at UVA receive this national honor for our work to provide excellent, comprehensive care to patients throughout the region," said Bobby Chhabra, MD, chair of the UVA Department of Orthopedic Surgery. Becker's says the hospitals included on its list have been recognized for excellence from various other publications and industry organizations, including U.S.
- Written by Editor-in-Chief
- Category: Industry News
VANCOUVER, BC--(Marketwired - November 10, 2016) -According to a new series of reports on the U.S. market for anesthesia, respiratory and sleep management (ARS) devices by iData Research (www.idataresearch.com), the market is largely influenced by insurance policies, especially when it comes to durable devices governed under the durable manufacturer equipment (DME) realm. Beginning in January of 2016, the U.S. Congress dramatically cut reimbursement for home oxygen services by applying competitive rates in geographic areas that were previously excluded from competitive bidding. Some providers of home oxygen therapy have already started planning in order to stay operational in the face of such drastic shortfalls, which could result in the elimination of many of the critical services upon which patients have come to depend.
- Written by Editor-in-Chief
- Category: Industry News
VANCOUVER, BC--(Marketwired - November 10, 2016) - According to a new series of reports on the U.S. market for anesthesia, respiratory and sleep management (ARS) devices by iData Research (www.idataresearch.com), the market is largely influenced by insurance policies, especially when it comes to durable devices governed under the durable manufacturer equipment (DME) realm. Beginning in January of 2016, the U.S. Congress dramatically cut reimbursement for home oxygen services by applying competitive rates in geographic areas that were previously excluded from competitive bidding. Some providers of home oxygen therapy have already started planning in order to stay operational in the face of such drastic shortfalls, which could result in the elimination of many of the critical services upon which patients have come to depend.
- Written by eoliver@beckershealthcare.com (Eric Oliver)
- Category: Industry News
Here's what you need to know. 1. HHS Inspector General Daniel R. Levinson told Senator Charles Grassley (R-Iowa) of the findings Oct. 8, 2016. Mylan agreed to a $465 million settlement with CMS last month. 2. The disclosure from HHR raise questions on why Mylan took so long to correct the error, what steps CMS took to inform Mylan of the error and why Mylan didn't disclose the information with its investors. 3. U.S. Securities regulators issued a subpoena for Mylan's communications with CMS.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are five report highlights: 1. Globus saw $0.29 earnings per share in Q3, surpassing Thomson Reuters' consensus estimate of $0.28. 2. The company saw revenue of $135.7 million in Q3 2016, under analyst estimates of $139.25 million. 3. Q3 revenue decreased 1 percent compared to the same period in 2015. 4. Globus reported a net margin of 21.19 percent as well as a return on equity of 15.43 percent. 5. The company updated its fiscal year 2016 guidance to $1.20 EPS.
Submit Community Content
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!